Using ventilator splitters during the COVID-19 pandemic--letter to health care providers.

Press Release/Announcement

Using ventilator splitters during the COVID-19 pandemic--letter to health care providers.

February 17, 2021

Silver Spring, MD: Division of Industry and Consumer Education, US Food and Drug Administration; February 9. 2021.

Lack of access to ventilators during the COVID-19 crisis has necessitated care compromises to support multiple patients. This situation can reduce the effectiveness of monitoring patients on shared devices and introduce other challenges. This communication provides insights to enhance the safety of multiple-patient ventilator use.

Free full text

Related Resources From the Same Author(s)

Five Medication Safety Tips for Older Adults.

February 15, 2024

FDA 101: How to Use the Consumer Complaint System and MedWatch.

June 25, 2008

Apotex Corp. issues voluntary nationwide recall of Enoxaparin Sodium Injection, USP due to mislabeling of syringe barrel measurement markings.

February 17, 2021

Making Medical Devices Safer at Home.

January 9, 2013

Safety Problems With Your Child's Medical Device?

July 31, 2013

Important information for the safe use of Tussionex Pennkinetic Extended-Release Suspension.

March 26, 2008

Testing and Labeling Medical Devices for Safety in the Magnetic Resonance (MR) Environment.

June 2, 2021

FDA requires label warnings to prohibit sharing of multi-dose diabetes pen devices among patients.

March 11, 2015

Design of endoscopic retrograde cholangiopancreatography (ERCP) duodenoscopes may impede effective cleaning.

March 4, 2015

Hydrocodone bitartrate and acetaminophen tablets, phenobarbital tablets by Qualitest: recall—incorrect package labeling.

February 16, 2011

Codeine use in certain children after tonsillectomy and/or adenoidectomy may lead to rare, but life-threatening adverse events or death.

February 20, 2013

Heparin sodium injection 10,000 units/mL, and HEP-LOCK U/P 10 units/mL medication errors.

February 21, 2007

Important Warnings and Instructions for Heparin Sodium Injection (Baxter).

February 20, 2008

FDA identifies harm reported from sudden discontinuation of opioid pain medicines and requires label changes to guide prescribers on gradual, individualized tapering.

April 17, 2019

Relenza (zanamivir) inhalation powder.

October 21, 2009

Meitheal Pharmaceuticals, Inc. issues voluntary nationwide recall of Cisatracurium Besylate Injection, USP 10mg per 5mL due to mislabeling.

February 10, 2021

FDA updates vinca alkaloid labeling for preparation in intravenous infusion bags only.

February 3, 2021

Hospira issues a voluntary nationwide recall for one lot of 0.5% Bupivacaine Hydrochloride Injection, USP and one lot of 1% Lidocaine HCl Injection, USP due to mislabeling.

May 19, 2021

Potential for medication overdose with ENFit low dose tip syringe: FDA Safety Communication.

October 20, 2021

Cardinal Health recalls Argyle UVC insertion tray due to missing instructions for use for the Safety Scalpel N11.

September 1, 2021

FDA Safety Communication: update--robotically-assisted surgical devices in mastectomy.

August 20, 2021

My Medicines.

July 9, 2014

FDA alerts patients and health care professionals of EpiPen auto-injector errors related to device malfunctions and user administration.

April 8, 2020

Medication errors resulting from confusion between risperidone (Risperdal) and ropinirole (Requip).

June 22, 2011

Drug Shortages: Root Causes and Potential Solutions.

November 13, 2019

Computerized Prescriber Order Entry Medication Safety (CPOEMS): Uncovering and Learning From Issues and Errors.

January 13, 2016

FDA public health notification: unretrieved device fragments.

January 30, 2008

FDA recommends health care professionals discuss naloxone with all patients when prescribing opioid pain relievers or medicines to treat opioid use disorder.

August 5, 2020

Wear face masks with no metal during MRI exams.

December 16, 2020

FDA advises health care professionals and patients about insulin pen packaging and dispensing.

October 28, 2020

FDA alerts health care professionals to the temporary absence of warning statement on the vial caps of two neuromuscular blocking agents.

July 15, 2020

Golden State Medical Supply, Inc. Issues a Voluntary Nationwide Recall of Atenolol 25 mg Tablets and Clopidogrel 75 mg Tablets Due to a Label Mix-up.

October 19, 2022

Use duodenoscopes with innovative designs to enhance safety: FDA Safety Communication.

May 4, 2022

Implantable infusion pumps in the magnetic resonance (MR) environment: FDA safety communication—important safety precautions.

January 25, 2017

Infections associated with reprocessed flexible bronchoscopes.

September 30, 2015

FDA Drug Safety Communication: FDA warns about prescribing and dispensing errors resulting from brand name confusion with antidepressant Brintellix (vortioxetine) and antiplatelet Brilinta (ticagrelor).

August 12, 2015

Potentially fatal errors with GDH-PQQ [glucose dehydrogenase pyrroloquinoline quinone] glucose monitoring technology.

October 21, 2009

Tamiflu (oseltamivir) for oral suspension: potential medication errors.

October 7, 2009

Morphine sulfate oral solution 100 mg per 5 mL (20 mg/mL): medication use error—reports of accidental overdose.

January 19, 2011

FDA requiring color changes to Duragesic (fentanyl) pain patches to aid safety―emphasizing that accidental exposure to used patches can cause death.

October 9, 2013

Important change to heparin container labels to clearly state the total drug strength.

December 19, 2012

Kadcyla (ado-trastuzumab emtansine): drug safety communication—potential medication errors resulting from name confusion.

May 15, 2013

Luer Connector Misconnections: Under-Recognized but Potentially Dangerous Events.

August 15, 2012

Hospira Carpuject pre-filled cartridges—drug alert: products may contain more than the intended fill volume.

May 30, 2012

A Review of FDA’s Approach to Medical Product Shortages.

November 16, 2011

Serious adverse events from accidental ingestion by children of over-the-counter eye drops and nasal sprays.

November 7, 2012

Medical Device Safety Action Plan: Protecting Patients, Promoting Public Health.

June 6, 2018

FDA Safety Communication: use caution with implanted pumps for intrathecal administration of medicines for pain management.

November 28, 2018

FDA Safety Communication: recommendations to reduce surgical fires and related patient injury.

June 20, 2018

FDA Drug Safety Communication: FDA requires labeling changes for prescription opioid cough and cold medicines to limit their use to adults 18 years and older.

February 7, 2018

FDA Funding Available for Research Aimed at Reducing Preventable Harm from Medication

November 6, 2019

Information for healthcare professionals: risk of transmission of blood-borne pathogens from shared use of insulin pens.

April 8, 2009

ReliOn insulin syringes for use with U-100 insulin (Tyco Healthcare-Covidien).

November 19, 2008

An Introduction to the Improved FDA Prescription Drug Labeling.

November 1, 2006

Roxane Laboratories initiates a nationwide voluntary recall of a single manufacturing lot of Azathioprine tablets in the U.S. and Puerto Rico.

July 26, 2006

FDA Safety Communication: flexible bronchoscopes and updated recommendations for reprocessing.

February 24, 2022 - February 24, 2022

FDASIA Health IT Report: Proposed Strategy and Recommendations for a Risk-Based Framework.

April 30, 2014

Medication Safety During the COVID-19 Pandemic: What Have We Learned in the United States.

June 23, 2020

FDA preliminary public health notification: unpredictable events in medical equipment due to new daylight savings time change.

January 9, 2005

FDA Pharmacists Help Consumers Use Medicines Safely.

November 19, 2014

Strategic Plan for Preventing and Mitigating Drug Shortages.

November 13, 2013

Heparin-containing medical devices and combination products: recommendations for labeling and safety testing. Draft guidance for industry and Food and Drug Administration staff.

August 5, 2015

Safety considerations to mitigate the risks of misconnections with small-bore connectors intended for enteral applications.

March 4, 2015

Maalox Total Relief and Maalox Liquid Products: Medication Use Errors.

March 3, 2010

Accidental exposures to fentanyl patches continue to be deadly to children.

July 21, 2021

Best Practices in Developing Proprietary Names for Human Nonprescription Drug Products.

January 13, 2021

Best Practices in Developing Proprietary Names for Human Prescription Drug Products Guidance for Industry.

December 23, 2020

Safety Considerations for Container Labels and Carton Labeling Design to Minimize Medication Errors: Guidance for Industry.

May 25, 2022

Reporting of death in US Food and Drug Administration medical device adverse event reports in categories other than death.

August 11, 2021

Safety Considerations for Product Design to Minimize Medication Errors: Guidance for Industry.

January 9, 2013

Clinical Decision Support Software: Guidance for Industry and Food and Drug Administration Staff.

October 3, 2022

Nimodipine Capsules (marketed as Nimotop).

March 1, 2006

Public Health Notification from FDA: Vail Products Enclosed Bed Systems.

December 19, 2007

Letter to Health Care Providers: Safe Use of Surgical Staplers and Staples.

October 7, 2021

Use purple bracelets or wristbands only for do not resuscitate status - letter to industry.

August 25, 2021

CLER Report of Findings 2021: Subprotocol for Operative and Procedural Areas.

April 28, 2021

Postmarket Drug Safety Information for Patients and Providers.

November 19, 2008

Questions and Answers on FDA's Adverse Event Reporting System (FAERS).

September 17, 2008

Examples of Medical Device Misconnections.

March 8, 2023

Bar code label requirement for human drug products and biological products.

March 27, 2005

Initiative to Reduce Unnecessary Radiation Exposure from Medical Imaging.

March 3, 2010

Human Factors and Medical Devices.

March 27, 2005

Potential for false positive results with antigen tests for rapid detection of SARS-CoV-2--letter to clinical laboratory staff and health care providers.

November 11, 2020

FDA Drug Safety Communication: FDA cautions about dosing errors when switching between different oral formulations of antifungal Noxafil (posaconazole); label changes approved.

January 13, 2016

OpenFDA.

June 11, 2014

Be an Active Member of Your Health Care Team.

May 21, 2014

Drug Shortages.

April 27, 2011

Reprocessing of Reusable Medical Devices.

January 11, 2012

Lock it Up: Medicine Safety in Your Home.

November 30, 2011

BeSafeRx: Know Your Online Pharmacy.

October 10, 2012

Teaching Kids About Using Medicine Safely.

February 29, 2012

Differences in strength expression on product labels of compounders and conventional manufacturers may lead to dosing errors.

October 10, 2018

FDA MedWatch and Patient Safety Tutorial.

December 10, 2008

Fentanyl transdermal system (marketed as Duragesic) information.

July 10, 2015

MedWatch: The FDA Safety Information and Adverse Event Reporting Program.

June 22, 2005

FDA Guidance Document: Hospital Bed System Dimensional and Assessment Guidance to Reduce Entrapment.

June 7, 2006

Hospital Bed System Dimensional and Assessment Guidance to Reduce Entrapment.

March 22, 2006

Using Innovative Digital Healthcare Solutions to Improve Quality at the Point of Care (R21/R33 - Clinical Trial Optional).

February 24, 2021

Use of recalled devices in new device authorizations under the US Food and Drug Administration's 510(k) pathway and risk of subsequent recalls.

January 25, 2023

Promethazine HCl (marketed as Phenergan) Information.

May 3, 2006

Related Resources

Healthcare-associated infections in Veterans Affairs acute-care and long-term healthcare facilities during the coronavirus disease 2019 (COVID-19) pandemic.

April 5, 2023

COVID-19 in Nursing Homes: CMS Needs to Continue to Strengthen Oversight of Infection Prevention and Control.

October 12, 2022

Recommendations for the safety of hospitalised patients in the context of the COVID-19 pandemic: a scoping review.

October 5, 2022

Clinic design for safety during the pandemic: safety or teamwork, can we only pick one?

May 11, 2022

Use duodenoscopes with innovative designs to enhance safety: FDA Safety Communication.

May 4, 2022

What is needed to sustain improvements in hospital practices post-COVID-19? A qualitative study of interprofessional dissonance in hospital infection prevention and control.

May 4, 2022

COVID-19 Focused Inspection Initiative in Healthcare.

March 23, 2022

Patient Safety Primers

Coronavirus Disease 2019 (COVID-19) and Safety of Older Adults Residing in Nursing Homes

February 24, 2022

Health care safety during the pandemic and beyond--building a system that ensures resilience.

February 23, 2022

Coronavirus disease 2019 (COVID-19) pandemic, central-line-associated bloodstream infection (CLABSI), and catheter-associated urinary tract infection (CAUTI): the urgent need to refocus on hardwiring prevention efforts.

February 7, 2022

Impact of full personal protective equipment on alertness of healthcare workers: a prospective study.

February 2, 2022

Using smart IV infusion pumps outside of patient rooms.

February 2, 2022

NPSD Data Spotlight, Patient Safety and COVID-19: A Qualitative Analysis of Concerns During the Public Health Emergency, 2021.

December 22, 2021

Age-related COVID-19 vaccine mix-ups.

December 15, 2021

Nursing strategies to safeguard COVID-19 patients from harm in the intensive care unit.

December 8, 2021

Transmission of community- and hospital-acquired SARS-CoV-2 in hospital settings in the UK: a cohort study.

November 10, 2021

Agency information collection activities: National Healthcare Safety Network (NHSN); comment request.

October 13, 2021

The impact of coronavirus disease 2019 (COVID-19) on healthcare-associated infections in 2020: a summary of data reported to the National Healthcare Safety Network.

September 22, 2021

Role of nursing home quality on COVID-19 cases and deaths: evidence from Florida nursing homes.

September 22, 2021

Inpatient telemedicine and new models of care during COVID-19: hospital design strategies to enhance patient and staff safety.

September 15, 2021

Cardinal Health recalls Argyle UVC insertion tray due to missing instructions for use for the Safety Scalpel N11.

September 1, 2021

Impact of COVID-19 on inpatient clinical emergencies: a single-center experience.

June 9, 2021

The calm before the storm: utilizing in situ simulation to evaluate for preparedness of an alternative care hospital during COVID-19 pandemic.

June 2, 2021

Maintaining maternal-newborn safety during the COVID-19 pandemic.

May 26, 2021

Clinical characteristics and short-term outcomes of acute kidney injury missed diagnosis in older patients with severe COVID-19 in intensive care unit.

May 19, 2021

AHRQ Safety Program for Methicillin-Resistant Staphylococcus Aureus Prevention. Request for Proposal Comment.

May 19, 2021

Ethical considerations and patient safety concerns for cancelling non-urgent surgeries during the COVID-19 pandemic: a review.

May 12, 2021

Universal protection: operationalizing infection prevention guidance in the COVID-19 era.

May 12, 2021

The perception of patient safety in an alternate site of care for elective surgery during the first wave of the novel coronavirus pandemic in the United Kingdom: a survey of 158 patients.

March 24, 2021

COVID-19 increased the risk of ICU-acquired bloodstream infections: a case-cohort study from the multicentric OUTCOMEREA network.

March 17, 2021

See More About The Topic

Intensive Care Units

Health Care Executives and Administrators

Quality and Safety Professionals

Public Health

Infectious Diseases